NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

NRx Pharmaceuticals Inc (NASDAQ: NRXP)

 
NRXP Technical Analysis
4
As on 1st Jul 2025 NRXP SHARE Price closed @ 3.13 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.89 & Strong Buy for SHORT-TERM with Stoploss of 0.46 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NRXPSHARE Price

Open 3.25 Change Price %
High 3.25 1 Day -0.13 -3.99
Low 3.10 1 Week -0.13 -3.99
Close 3.13 1 Month 0.68 27.76
Volume 186404 1 Year 2.70 627.91
52 Week High 5.53 | 52 Week Low 0.29
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
ARBK 0.37 94.74%
ARBK 0.37 94.74%
NVDA 153.30 -2.97%
LCID 2.03 -3.79%
HCTI 0.03 0.00%
TSLA 300.71 -5.34%
HOOD 92.33 -1.39%
LMDX 0.02 0.00%
OPEN 0.56 5.66%
 
NASDAQ USA Top Gainers Stocks
HSDT 8.60 4677.78%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
TBIO 0.30 500.00%
NBSTU 12.99 220.74%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
SRAX 0.01 -66.67%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.12 -62.50%
 
 
NRXP
Daily Charts
NRXP
Intraday Charts
Whats New @
Bazaartrend
NRXP
Free Analysis
 
NRXP Important Levels Intraday
RESISTANCE3.42
RESISTANCE3.33
RESISTANCE3.27
RESISTANCE3.21
SUPPORT3.05
SUPPORT2.99
SUPPORT2.93
SUPPORT2.84
 
NRXP Forecast July 2025
4th UP Forecast3.52
3rd UP Forecast3.39
2nd UP Forecast3.32
1st UP Forecast3.24
1st DOWN Forecast3.02
2nd DOWN Forecast2.94
3rd DOWN Forecast2.87
4th DOWN Forecast2.74
 
NRXP Weekly Forecast
4th UP Forecast3.34
3rd UP Forecast3.27
2nd UP Forecast3.23
1st UP Forecast3.19
1st DOWN Forecast3.07
2nd DOWN Forecast3.03
3rd DOWN Forecast2.99
4th DOWN Forecast2.92
 
NRXP Forecast2025
4th UP Forecast14.17
3rd UP Forecast10.63
2nd UP Forecast8.44
1st UP Forecast6.25
1st DOWN Forecast0.01
2nd DOWN Forecast-2.18
3rd DOWN Forecast-4.37
4th DOWN Forecast-7.91
 
 
NRXP Other Details
Segment EQ
Market Capital 536121824.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NRXP Address
NRXP
 
NRXP Latest News
 
Your Comments and Response on NRx Pharmaceuticals Inc
 
NRXP Business Profile
NRX Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops various therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company's pipeline includes medicinal candidates in Phase 2 and Phase 3 trials for COVID-19-related lung injury and acute respiratory distress. Its products include ZYESAMI, an investigational pre-commercial drug for COVID-19 related respiratory failure; and NRX-100/101, an investigational pre-commercial drug for treating bipolar depression in patients with acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware. Address: 1201 Orange Street, Wilmington, DE, United States, 19801
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service